Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, David Stejskal, Zhiguang Zhou, Feng Liu, Rachel L.C. Wong, Wing‐Sun Chow, Annette W.K. Tso, Karen S.L. Lam, Aimin Xu
Materialtyp: Artigo
Språk:engelska
Publicerad: 2008
Länkar:https://doi.org/10.2337/db07-1476
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Internet

https://doi.org/10.2337/db07-1476

Liknande verk